$1 Trial Offer - Realtime Screener -- Try out our Realtime Product, GetStockIdeas. The advanced screener tool is a momentum trader's dream!

Amarantus Bioscience Holdings, Inc.
(Other OTC/NBB : AMBS)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
Loading AMBS News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
0.27%81.691.6%$1010.80m
BIIBBiogen Inc.
0.53%319.851.2%$631.89m
AMGNAmgen Inc.
0.07%174.521.0%$524.07m
CELGCelgene Corporation
0.73%114.840.8%$510.92m
MDVNMedivation, Inc.
0.08%80.331.8%$360.91m
REGNRegeneron Pharmaceuticals, Inc.
0.53%422.843.4%$324.33m
ILMNIllumina, Inc.
0.09%172.954.4%$241.76m
BMRNBioMarin Pharmaceutical Inc.
2.31%101.733.6%$211.44m
ALXNAlexion Pharmaceuticals, Inc.
0.22%137.732.6%$202.73m
VRTXVertex Pharmaceuticals Incorporated
0.54%101.532.3%$127.65m
EXASExact Sciences Corporation
-0.81%20.2630.9%$123.69m
IONSIonis Pharmaceuticals, Inc.
1.25%34.1311.1%$100.81m
INCYIncyte Corporation
1.43%83.072.6%$94.82m
AAgilent Technologies, Inc.
-0.17%47.740.9%$91.72m
TSROTESARO, Inc.
-0.43%92.3615.8%$87.73m

Company Profile

Amarantus BioScience Holdings, Inc. is a publicly traded biotechnology company focused on developing therapeutic products with the potential for orphan drug designation in the areas of neurology, psychiatry, ophthalmology and regenerative medicine, and diagnostics in neurology. The company was founded by Gerald E. Commissiong and John W. Commissiong on January 14, 2008 and is headquartered in San Francisco, CA.